| Members |
targetComponentId |
| Diff. white cell count NOS |
Differential white blood cell count procedure |
| Difficult intubation |
Difficult intubation |
| Difficulty speaking |
Difficulty talking |
| Diffuse large B-cell lymphoma (nodal/systemic with skin involvement) |
Diffuse large B-cell malignant lymphoma (disorder) |
| Diffuse large B-cell lymphoma - category |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
| Diffuse neurodermatitis of Brocq |
Atopic dermatitis |
| Diffuse non-Hodgkin's lymphoblastic (diffuse) lymphoma |
Precursor cell lymphoblastic lymphoma |
| Diffuse non-Hodgkin's lymphoma, lymphoblastic |
Precursor cell lymphoblastic lymphoma |
| Diffuse unilateral subacute neuroretinitis |
Diffuse unilateral subacute neuroretinitis |
| Diflucan oral suspension |
Fluconazole-containing product in oral dose form |
| Difluprednate 0.05% ophthalmic emulsion |
Difluprednate 500 microgram/mL eye suspension |
| Digestant |
Digestant (substance) |
| Digestive endoscope |
Endoscope |
| Digestive function tests NOS |
Digestive function tests |
| Digestive function tests NOS |
Digestive function tests |
| Digestive system diseases NOS |
Disorder of digestive system (disorder) |
| Digestive system diseases NOS |
Disorder of digestive system (disorder) |
| Digoxin 38mg/vial injection |
Digoxin immune fab only product |
| Digoxin immune fab 38mg/vial powder for injection 4mL vial |
Digoxin immune fab only product |
| Digoxin specific antibody 38mg powder for injection solution vial |
Digoxin immune fab only product |
| Dihydrocarbostyril derivative antipsychotic agent |
Dihydrocarbostyril derivative |
| Dihydroergotamine mesylate 1mg/mL injection solution ampule |
Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Dihydroergotamine mesylate 4mg/1mL nasal spray |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
| Dihydroergotamine mesylate allergy |
Allergy to dihydroergotamine |
| Dihydrofolate reductase deficiency |
Deficiency of dihydrofolate reductase |
| Dihydroindolone derivative antipsychotic agent |
Dihydroindolone derivative (substance) |
| Dihydrotachysterol 0.2mg/mL |
Product containing dihydrotachysterol (medicinal product) |
| Dihydrotachysterol 170mg |
Product containing dihydrotachysterol (medicinal product) |
| Dilatation and curettage NOS |
Dilation and curettage |
| Dilatation and curettage NOS |
Dilation and curettage |
| Dilatation of gastrointestinal tract NOS |
Dilation of gastrointestinal tract |
| Dilatation of gastrointestinal tract NOS |
Dilation of gastrointestinal tract |
| Dilatation: [other opening] or [non GIT] |
Dilation procedure |
| Dilatation: [other opening] or [non GIT] |
Dilation procedure |
| Dilation of cervix uteri and curettage of uterus NEC |
Dilation and curettage of uterus |
| Dilation of cervix uteri and curettage of uterus NEC |
Dilation and curettage of uterus |
| Dilation of cervix uteri and evacuation of products of conception from uterus NEC |
Evacuation of retained product of conception |
| Dilation of colon |
Dilation of colon |
| Dilation of colostomy stoma |
Dilation of colostomy stoma |
| Dilation of mature percutaneous transhepatic biliary drainage tract under radiological guidance |
Fluoroscopy guided dilation of mature percutaneous transhepatic biliary drainage tract |
| Dilation of organ NOC |
Dilation procedure |
| Dilation of organ NOC NOS |
Dilation procedure |
| Dilation of stricture of organ NOC |
Dilation procedure |
| Diltiazem 180mg m/r tablet |
Diltiazem only product in oral dose form |
| Diltiazem 180mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
| Diltiazem 240mg m/r tablet |
Diltiazem only product in oral dose form |
| Diltiazem 240mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
| Diltiazem 300mg m/r tablet |
Diltiazem only product in oral dose form |
| Diltiazem 300mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
| Diltiazem 360mg m/r tablet |
Diltiazem only product in oral dose form |
| Diltiazem 360mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
| Diltiazem 420mg m/r tablet |
Diltiazem only product in oral dose form |
| Diltiazem 420mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 420mg m/r capsule |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 420mg prolonged-release oral capsule |
Diltiazem only product in oral dose form |
| Diltiazem hydrochloride 5mg/mL solution |
Product containing only diltiazem in parenteral dose form (medicinal product form) |
| Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
| Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
| Dimeglumine gadopentetate 469.01mg/mL injection solution prefilled syringe |
Gadopentetic acid only product |
| Dimeglumine gadopentetate 469.01mg/mL injection solution vial |
Gadopentetic acid only product |
| Dingo dog breed |
Canis lupus dingo |
| Dinoprostone 10mg insert |
Dinoprostone 10 mg prolonged-release vaginal pessary |
| Dinoprostone 10mg suppository |
Dinoprostone 10 mg prolonged-release vaginal pessary |
| Dinoprostone 10mg/mL infusion concentrate 0.5mL ampule |
Dinoprostone 10 mg/mL solution for injection |
| Dinoprostone 1mg/mL infusion concentrate 0.75mL ampule |
Dinoprostone 1 mg/mL solution for injection |
| Dioxygenase |
Dioxygenase |
| Dipeptide hydrolase |
Dipeptide hydrolase |
| Dipeptidyl carboxypeptidase II |
Dipeptidyl carboxypeptidase II (substance) |
| Dipeptidylpeptide hydrolase |
Dipeptidylpeptide hydrolase (substance) |
| Dipetalonema perstans |
Mansonella perstans (organism) |
| Diphenhydramine 2%/zinc acetate 0.1% topical cream |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
| Diphenhydramine hydrochloride 12.5mg/5mL elixir |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Diphenhydramine hydrochloride 12.5mg/5mL syrup |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Diphenhydramine hydrochloride 6.25mg/5mL syrup |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
| Diphenhydramine hydrochloride 6.25mg/5mL syrup |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
| Diphenylmethane diisocyanate specific extract |
Diphenylmethane di-isocyanate |
| Diphtheria and tetanus double vaccination NOS |
Administration of diphtheria and tetanus vaccine |
| Diphtheria and tetanus double vaccination NOS |
Administration of diphtheria and tetanus vaccine |
| Diphtheria toxin skin test |
Diphtheria toxin |
| Diphtheria vaccination NOS |
Administration of diphtheria vaccine |
| Diphtheria vaccination NOS |
Administration of diphtheria vaccine |
| Diphtheria, pertussis and tetanus triple vaccination |
Administration of diphtheria, pertussis, and tetanus vaccine |
| Diphtheria, pertussis and tetanus triple vaccination NOS |
Administration of diphtheria, pertussis, and tetanus vaccine |
| Diphtheria, pertussis and tetanus triple vaccination NOS |
Administration of diphtheria, pertussis, and tetanus vaccine |
| Dipivefrin hydrochloride 0.1% eye drops |
Dipivefrine hydrochloride 1 mg/mL eye solution |
| Dipivefrin hydrochloride 0.1% ophthalmic solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
| Dipivefrin hydrochloride 0.1%wv solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
| Direct inguinal hernia NOS |
Direct inguinal hernia |
| Direct inguinal hernia NOS |
Direct inguinal hernia |
| Direct invasion of adrenal (T3a) |
American Joint Committee on Cancer cT3a (qualifier value) |
| Direct laryngoscopy with injection into vocal cord, therapeutic |
Direct laryngoscopy with injection into vocal cord (procedure) |
| Direct laryngoscopy, diagnostic, newborn |
Direct laryngoscopy |
| Direct laryngoscopy, diagnostic, with operating microscope |
Direct laryngoscopy with operating microscope (procedure) |
| Direct puncture operative cholangiography |
Intraoperative fluoroscopic cholangiography by direct puncture with contrast (procedure) |
| Director/producer/manager NOS |
Directors/producers/managers |
| Director/producer/manager NOS |
Directors/producers/managers |
| Dirty environment |
Dirty environment (finding) |
| Disabled driver report NOS |
Disabled driver report status |
| Disabled driver report NOS |
Disabled driver report status |
| Disabled registration application - NOS |
Disabled registration application status |
| Disabled registration application - NOS |
Disabled registration application status |
FHIR